- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04441242
Ambient Lighting During Colonoscopy and Its Effect on Adenoma Detection Rate and Eye Fatigue
June 18, 2020 updated by: Advocate Health Care
Use of Ambient Lighting During Colonoscopy and Its Effect on Adenoma Detection Rate and Eye Fatigue: a Pilot Study
A retrospective and prospective study to determine if the use of ambient lighting during screening colonoscopy is well tolerated and if ambient lighting will help physicians maintain adenoma detection rates while decreasing symptoms of eye strain as the day progresses.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This study is a a single-center study at an independent community-based teaching hospital comparing adenoma detection rate in screening colonoscopies performed in low lighting with those performed with ambient lighting (75-150 lux).
All cases included in the study involved adult patients undergoing screening colonoscopy with a participating gastroenterologist.
Diagnostic colonoscopies, history of colon resection, colorectal cancer, and cases performed in children, pregnant women, and prisoners were excluded from analysis.
Cases involving gastroenterology fellows were also excluded.
Retrospective data was collected over a six month period from January 2017 to June 2017, followed by a prospective arm the during the same calendar months the subsequent year (January 2018 to June 2018).
Study Type
Interventional
Enrollment (Actual)
1109
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Park Ridge, Illinois, United States, 60068
- Advocate Lutheran General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults undergoing screening colonoscopy
- Procedure performed by a participating gastroenterologist
Exclusion Criteria:
- Any diagnostic colonoscopies
- History of colon resection
- History of colorectal cancer
- Children
- Pregnant women
- Prisoners
- Cases involving trainees, including gastroenterology fellows
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Retrospective: Low lighting during screening colonoscopy
Screening colonoscopies performed with low lighting conditions.
|
Use of low lighting (<75 lux) in endoscopy room.
|
Active Comparator: Prospective: Ambient lighting during screening colonoscopy
Screening colonoscopies performed with ambient lighting conditions.
|
Use of ambient lighting (75-150 lux) in endoscopy room.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in adenoma detection rate
Time Frame: 6 months
|
Adenoma detection rate, comparing change from first case of the day to the last.
Ranges from 0-99%, with greater increases ADR being more favorable.
|
6 months
|
Eye strain score
Time Frame: 6 months
|
Eye strain score, as calculated from survey responses completed by physicians.
Ranges from 0 - 60, with lower scores indicating less severe symptoms (therefore, lower scores are more favorable).
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adenoma detection rate (overall)
Time Frame: Participants each assessed on one day during 6 month study period
|
Overall adenoma detection rate.
Ranges from 0% to 100%.
Higher ADR is more favorable.
|
Participants each assessed on one day during 6 month study period
|
Adenoma detection rate (first case vs last case of the day)
Time Frame: Participants each assessed on one day during 6 month study period
|
Adenoma detection rate, comparing first case of the day to the last.
Ranges from from -99 to 99%, with greater numbers (increases) being more favorable.
|
Participants each assessed on one day during 6 month study period
|
Satisfaction by staff
Time Frame: 6 months
|
Satisfaction by staff involved in endoscopy, based on survey responses
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hayes JR, Sheedy JE, Stelmack JA, Heaney CA. Computer use, symptoms, and quality of life. Optom Vis Sci. 2007 Aug;84(8):738-44. doi: 10.1097/OPX.0b013e31812f7546.
- Almadi MA, Sewitch M, Barkun AN, Martel M, Joseph L. Adenoma detection rates decline with increasing procedural hours in an endoscopist's workload. Can J Gastroenterol Hepatol. 2015 Aug-Sep;29(6):304-8. doi: 10.1155/2015/789038. Epub 2015 May 21.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
June 30, 2018
Study Completion (Actual)
June 30, 2018
Study Registration Dates
First Submitted
June 2, 2020
First Submitted That Met QC Criteria
June 18, 2020
First Posted (Actual)
June 22, 2020
Study Record Updates
Last Update Posted (Actual)
June 22, 2020
Last Update Submitted That Met QC Criteria
June 18, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6665
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer Screening
-
Memorial Sloan Kettering Cancer CenterRalph Lauren Center for Cancer Care and Prevention; North General Hospital,...Completed
-
Sunil PatelCompletedColonoscopy | Mass Screening | Colorectal Cancer ScreeningCanada
-
Harvard School of Public Health (HSPH)National Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer Screening | Implementation | Colorectal Cancer ScreeningUnited States
-
Motus GI Medical Technologies LtdRecruiting
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruitingColorectal Cancer | Gastrointestinal Microbiome | Colorectal Polyp | Mass ScreeningChina
-
Massachusetts General HospitalAgency for Healthcare Research and Quality (AHRQ)CompletedBreast Cancer Screening | Colon Cancer Screening | Prostate Cancer ScreeningUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); The Institute for Family HealthEnrolling by invitationColorectal Cancer ScreeningUnited States
-
University Paul Sabatier of ToulouseAssistance Publique Hopitaux De Marseille; Institut National de la Santé Et... and other collaboratorsActive, not recruitingColorectal Cancer ScreeningFrance
-
Florida A&M UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruiting
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute; Brigham and Women's Hospital; M... and other collaboratorsActive, not recruitingColorectal Cancer ScreeningUnited States
Clinical Trials on Low lighting
-
University of AarhusAarhus University HospitalCompleted
-
Icahn School of Medicine at Mount SinaiRecruitingSleep Disturbance | Alzheimer's DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiCompletedAlzheimer's DiseaseUnited States
-
Arizona State UniversityWithdrawnSleep | Alertness | Daytime Cognitive Performance
-
Well Living Lab, Inc.Mayo ClinicRecruitingPhysical Activity | Sleep | Cognitive Function | Social IsolationUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingAlzheimer Disease | Mild Cognitive ImpairmentUnited States
-
Icahn School of Medicine at Mount SinaiActive, not recruiting
-
University of IowaKenall ManufacturingWithdrawnBacterial Transmission | S.Aureus Transmission | Operating Room Exposure to S. Aureus | 90-day Postoperative Surgical Site Infections, Superficial and DeepUnited States
-
Massachusetts General HospitalMbarara University of Science and Technology; Harvard School of Public Health...CompletedHypertension | Pollution; Exposure | Pollution Related Respiratory DisorderUnited States, Uganda
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA); Rutgers UniversityRecruitingMild Cognitive Impairment | Alzheimer's DiseaseUnited States